|
|
|
Volumn 7, Issue 5 SUPPL., 2001, Pages
|
|
Surrogate endpoints and newer risk markers in atherosclerosis management
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
C REACTIVE PROTEIN;
COLESTIPOL;
FIBRINOGEN;
FISH OIL;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 6;
SIMVASTATIN;
ANGIOCARDIOGRAPHY;
ARTERY RUPTURE;
ATHEROSCLEROTIC PLAQUE;
BLOOD ANALYSIS;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY DISEASE;
CORONARY ARTERY THROMBOSIS;
CORRELATION FUNCTION;
DIAGNOSTIC IMAGING;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE MARKER;
DRUG MECHANISM;
HEALTH CARE MANAGEMENT;
HUMAN;
INTRAVASCULAR ULTRASOUND;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ARTERIOSCLEROSIS;
BIOLOGICAL MARKERS;
CLINICAL TRIALS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0035018831
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (6)
|
